Abstract: The present invention relates to an adherent interface dressing intended for application directly to a wound. Said adherent interface dressing includes a non-adherent cohesive gel formed from a hydrophobic elastomeric matrix consisting of a styrene-(ethylene/butylene)-styrene or styrene-(ethylene/propylene)-styrene triblock elastomer optionally associated with a styrene-(ethylene/butylene) or styrene-(ethylene/propylene) diblock copolymer; said elastomer plasticized by means of a mineral oil, and containing dispersed therein a small quantity of hydrophilic particles of a hydrocolloid; and a flexible open-mesh fabric, said fabric including threads coated with the non-adherent cohesive gel such as to leave the meshes substantially unsealed, The fabric is a heat-set knit with weft yarns, said yarns being continuous multifilament yarns with non-elastic filaments, whereof the extensibility in the transverse direction measured in accordance with standard EN 13726-4 is between 0.01 and 0.5 N/cm.

Abstract: The subject matter of the present invention is a bacterium or a mixture of bacteria having an antagonistic activity with respect to strains of S. aureus, P. aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur as well as the use thereof in the treatment and/or prevention of infections or colonizations related to those pathogens. The invention pertains to care products containing one or more non-pathogenic antagonistic strains intended to prevent and/or treat infections or colonizations on skin, wounds, mucous membranes and appendages.

Abstract: The present invention consists of a novel process for the incorporation of one or more water-soluble active agents in a hydrophilic polymer foam. Said process makes it possible in particular to obtain a hydrophilic polyurethane foam exhibiting a gradient of active agents. This process is of particular use when manufacturing hydrophilic polyurethane foams intended for medical, cosmetic and dermocosmetic purposes.

Abstract: The present disclosure relates to novel dressings containing polysulfated oligosaccharides having sustained release of the active ingredients. It also relates to a method for the preparation thereof, this method including a treatment step with ethylene oxide. It further relates to the uses thereof for wound care and the treatment and/or prevention of scars and stretch marks.

Abstract: Disclosed is an article that includes at least one polymeric substrate assembled on at least one layer of silicone polymer, characterized in that at least one of the polymeric substrate or the layer of silicone polymer has been brought into contact with particles of titanium dioxide, magnesium oxide and/or zinc oxide, before assembly of the article, and in that at least one of the polymeric substrate or the layer of silicone polymer has been brought into contact with water before or after assembly of the article. Also disclosed is a method of preparing the article, as well as the use of particles of titanium dioxide, magnesium oxide and/or zinc oxide, for improving the adherence between a polymeric substrate and a layer of silicone polymer.

Abstract: The present invention consists of a novel process for the incorporation of one or more water-soluble active agents in a hydrophilic polymer foam. Said process makes it possible in particular to obtain a hydrophilic polyurethane foam exhibiting a gradient of active agents. This process is of particular use when manufacturing hydrophilic polyurethane foams intended for medical, cosmetic and dermocosmetic purposes.

Abstract: The present invention relates to a compound selected among the synthetic polysulphated oligosaccharides having 1 to 4 ose units and the salts and complexes thereof to be used for the treatment of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars. Said use is preferred in particular in patients that have a predisposition to developing hypertrophic, retractile or atrophic scars. According to a second aspect, the invention also relates to said compound for the use thereof in order to inhibit the differentiation of fibroblasts into myofibroblasts during the cicatrisation of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars.

Abstract: The subject matter of the present invention is a photopolymerizable liquid composition comprising at least one epoxidized polybutadiene prepolymer, at least one cationic photoinitiator, and at least one thioxanthone-derived photosensitizer, which can, for example, be in the form of a liquid dressing. The subject matter of the invention is also a process for obtaining a polymerized film from said photopolymerizable liquid composition, characterized in that said composition is applied to tissues such as the skin, the skin appendages or the mucous membranes so as to form a uniform liquid film, and the film thus obtained is subjected to ultraviolet radiation, preferably ultraviolet-visible radiation having a wavelength of between 380 and 405 nm, preferably between 385 and 395 nm.

Abstract: The present invention relates to an item (10) having liquid (L) storage and/or discharge properties, in particular a bandage, comprising: —a liquid-permeable proximal structure (20), consisting of a material capable of inflating in the presence of liquid (L), —a distal structure (30) capable of draining a liquid (L), —a hydrophobic and non-absorbent spacer structure (40) extending between the distal (30) and proximal (20) structures, and being capable of locally limiting, when said material is not inflated, the exchange of liquid between the distal and proximal structures by maintaining a gap between said structures, and of authorizing a local expansion of the proximal structure in at least one zone (P) where said material is inflated in response to coming into contact with a liquid, said expansion causing the proximal and distal structure to move together locally and the transfer of said liquid from the zone of the proximal structure (20) having undergone expansion to the distal structure (30).

Abstract: The present invention relates to an absorbent dressing comprising a breathable impermeable substrate (4) and an absorbent foam (2), which is particularly suitable for use in the care of chronic or acute wounds. The invention relates to a dressing comprising an absorbent foam (2) and a protective substrate (4) that is impermeable to fluids, but permeable to water vapor, said substrate being formed by assembling a film (4a) and an openwork reinforcement that is coated with an adhesive silicone gel (4b) without blocking the openings in the reinforcement. In addition, the dressing comprises a non-absorbent web (5) which is disposed between the absorbent foam (2) and the substrate (4), which adheres to the adhesive silicone gel coating on the reinforcement, and which adheres to the absorbent foam (2).

Abstract: The present invention relates to a topical composition, in particular a cosmetic and/or dermatological composition, to be used for preventing and/or treating stretch marks, including, in a physiologically acceptable medium, an effective amount of at least one synthetic polysulfated oligosaccharide having 1 to 4 glycose units, the salts thereof, and/or the derivatives thereof. The invention also relates to a cosmetic method, in particular for treating stretch marks, including at least one step of applying said composition to the skin.

Abstract: The present invention relates to a topical film-forming composition including, in a pharmaceutically acceptable medium: 5 to 30 wt % of ethyl cellulose; 0.1 to 10 wt % of an auxiliary film-forming agent; 0.1 to 20 wt % of one or more triacids, at least one of which is boric acid; and 60 to 95 wt % of an organic solvent, the percentages being expressed by weight relative to the total weight of the composition. The invention also relates to the use of such a composition in a method for treating herpes, in particular herpes labialis.

Abstract: The subject matter of the present invention is a bacterium or a mixture of bacteria having an antagonistic activity with respect to strains of S. aureus, P. aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur as well as the use thereof in the treatment and/or prevention of infections or colonizations related to those pathogens. The invention pertains to care products containing one or more non-pathogenic antagonistic strains intended to prevent and/or treat infections or colonizations on skin, wounds, mucous membranes and appendages.

Abstract: A negative pressure wound treatment assembly comprising: a covering layer, a vacuum system comprising: a chamber having a tightly closed space with a reduced pressure, said chamber comprising an end closed by a perforable cap, a connecting device adapted to be attached to the covering layer and to the chamber to form a communication passage between the covering layer and the space of the chamber, the connecting device having at least one needle portion adapted to perforate the cap of the chamber, the connecting device comprising at least one valve member, wherein the valve member comprises a cover mounted on the needle portion, said cover covering a tipped end of the needle portion in a closing position and being adapted to be resiliently deformed to an opening position.

Abstract: The present invention relates to acetylsalicylic acid or a salt thereof, at a concentration comprised between 200 and 4800 ?M, for use in the prevention and/or treatment of diabetic wounds.

Abstract: The present disclosure relates to novel dressings containing polysulfated oligosaccharides having sustained release of the active ingredients. It also relates to a method for the preparation thereof, this method including a treatment step with ethylene oxide. It further relates to the uses thereof for wound care and the treatment and/or prevention of scars and stretch marks.

Abstract: The present invention relates to a bandage including an adhesive hydrocolloid mass, wherein said bandage includes, on at least one portion of the surface of the adhesive mass intended for being in contract with the wound when the bandage is being used, a plurality of agglomerates made up of particles linked to one another, preferably in a multi-layer configuration, at least 90% and preferably at least 95% of said particles being made up of one (or more) material(s) selected among polysaccharides, proteins and synthetic polymers, and being suitable for solubilizing or gelling in under ten seconds, and preferably still in less than one second when in contact with the exudate from the wound. The bandage according to the invention is intended for treating wounds such as blisters, exuding wounds, burns and dermal-epidermal lesions, whether superficial, deep, chronic or acute.

Abstract: The subject matter of the present invention is a system for measuring interface pressure exerted on the skin, that is in particular of use in compression therapy, characterized in that it comprises: —a supporting member bearing sensors, including at least two pressure sensors spaced out on the supporting member in order to make it possible to measure the pressure exerted at two predetermined positions; —an electronic system connected to the sensors and capable of acquiring the values simultaneously measured by these sensors; and in that each pressure sensor comprises a transducer element, which is preferably substantially flat, said transducer element having a surface intended to come into contact with the skin in the operating position, either directly or by means of a layer of a material covering said surface of the transducer, the elastic modulus of compression of said transducer or of said intermediate layer, measured at the surface intended to come into contact with the skin, being between 30 and 500 kPa

Abstract: The present invention relates to a composition in the fluid form intended to form a dressing on the skin. This composition comprises from 6% to 12% by weight of the total weight of the composition of a cellulose derivative, from 5% to 15% by weight of the total weight of the composition of a vegetable oil, and a volatile solvent. The oil/cellulose ratio by weight is between 0.8 and 1.5. This novel dressing base makes it possible to obtain a film on the skin having satisfactory resistances to water and to rubbing actions. The film is flexible and sufficiently comfortable, in particular when the dressing is applied to a fairly extensive area of the skin.

Abstract: The present invention relates to a topical composition, in particular a cosmetic and/or dermatological composition, to be used for preventing and/or treating stretch marks, including, in a physiologically acceptable medium, an effective amount of at least one synthetic polysulfated oligosaccharide having 1 to 4 glycose units, the salts thereof, and/or the derivatives thereof. The invention also relates to a cosmetic method, in particular for treating stretch marks, including at least one step of applying said composition to the skin.